Dyne Therapeutics Inc (NASDAQ:DYN) currently has a daily average trading volume of 2.48M but it saw 871326 shares traded in last market. With a market cap of 1.34B USD, the company’s current market price of $11.76 came rising about 0.51 while comparing to the previous closing price of $11.70. In past 52 weeks, the stock remained buoying in the range of price level as high as $47.45 and as low as $6.36.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BMO Capital Markets which initiated the stock as “Outperform” in its note to investors issued on March 12, 2025, recommending a price target of $50 for it. Robert W. Baird also issued its recommendations for the stock as it initiated the price target for the stock is $46.
Over the week, DYN’s stock price is moving -4.70% down while it is 4.26% when we observe its performance for the past one month. Year-to-date it is -50.08% down and over the past year, the stock is showing a downside performance of -62.37%.
Currently, Dyne Therapeutics Inc’s total number of outstanding shares is 113.63M with 0.69% of that held by the insiders while 110.42% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -53.42% and return on equity (ROE) at -64.01%. Stock’s beta reads 1.15. Stock has a price to book (P/B) ratio of 2.00. Its return on asset (ROA) is -59.05% on average.
